Literature DB >> 5052102

Determination of phenylbutazone in plasma.

E Jähnchen, G Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5052102

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics in the elderly.

Authors:  E J Triggs; R L Nation; A Long; J J Ashley
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

2.  Disposition and oxidative metabolism of phenylbutazone in man.

Authors:  J Aarbakke; O M Bakke; E J Milde; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

3.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 4.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

5.  Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

Authors:  W Schmidt; E Jähnchen
Journal:  J Pharmacokinet Biopharm       Date:  1979-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.